デフォルト表紙
市場調査レポート
商品コード
1797679

フラッシングソリューションの世界市場:タイプ・用途・エンドユーザー・地域別 (~2035年)

Global Flushing Solution Market Research Report by Type, by Application, by End User, and by Region Forecast till 2035


出版日
ページ情報
英文 124 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.30円
フラッシングソリューションの世界市場:タイプ・用途・エンドユーザー・地域別 (~2035年)
出版日: 2025年07月16日
発行: Market Research Future
ページ情報: 英文 124 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のフラッシングソリューションの市場規模は、2024年の11億1,605万米ドルから、予測期間中はCAGR 6.59%で推移し、2035年には22億1,496万米ドルとほぼ倍増すると予測されています。

フラッシングソリューションとは、医療機器が処置中に正常かつ安全に機能するように特別に作られた滅菌液です。これは、閉塞したデバイスを開通させ、開存性を維持し、カテーテル、点滴ライン、その他のアクセス用デバイスにおける感染リスクを減らす上で重要な役割を果たします。生理食塩水やヘパリン加生理食塩水が最も一般的なタイプの溶液です。

大腸内視鏡検査や上部消化管内視鏡検査などの診断手技への依存度の高まりが、世界のフラッシングソリューション市場を大きく押し上げています。がんや慢性疾患を含む消化器系疾患の症例増加は、正確なスクリーニングの重要性を強調しています。フラッシングソリューションは、これらの手技においてデバイスの開存性、患者の快適性、消化管の効果的な準備を保証します。技術革新や予防医療への意識の高まりに支えられ、今後10年間で世界的に特殊溶液の需要は加速していく見通しです。

地域分析

北米のフラッシングソリューション市場は、大規模に採用されている技術革新や患者志向のケアモデルの恩恵を受けています。米国は3億8,592万米ドルで北米市場を支配しており、カナダが5,190万米ドルで続き、米国が地域全体の主要な収益源であることを裏付けています。米国におけるこれら製品の需要は特に高く、これは長期的な静脈内治療を必要とする慢性疾患が現在広く存在していることに関連しています。

欧州は、フラッシングソリューションの世界市場における主要地域です。ドイツが8,927万米ドルでトップに立ち、英国が7,195万米ドル、フランスが6,406万米ドルで続いており、西欧市場の強さを示しています。この地域では、公立だけでなく私立の医療機関からも安定した需要が見られ、特に顕著なのは西欧地域における傾向です。

アジア太平洋市場の成長は、急速な都市化と増加し続ける医療インフラ投資によって牽引されています。中国が7,370万米ドルで市場をリードし、インドが5,636万米ドルで続き、両国が地域需要の中心となっていることを示しています。多国籍企業は、現地の販売業者との協力を通じてその存在感を活かしています。

当レポートでは、世界のフラッシングソリューションの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

第3章 調査手法

第4章 市場力学

  • 促進要因
    • 大腸内視鏡検査や内視鏡検査などの診断検査の増加
    • 腎臓結石の罹患率増加
  • 抑制要因
    • 厳格な規制要件
    • 発展途上地域における意識の欠如
  • 機会
    • 高齢化人口の増加
    • 低侵襲手術の採用増加

第5章 市場要因分析

  • ポーターのファイブフォースモデル
  • COVID-19が世界のフラッシングソリューション市場に与える影響

第6章 世界のフラッシングソリューション市場:タイプ別

  • 概要
  • 生理食塩水ベース
  • ヘパリンベース
  • その他

第7章 世界のフラッシングソリューション市場:用途別

  • 概要
  • 消化器系処置
  • 尿路フラッシング
  • 血管フラッシング
  • その他

第8章 世界のフラッシングソリューション市場:エンドユーザー別

  • 概要
  • 病院・専門クリニック
  • 外来手術センター
  • 研究機関

第9章 世界のフラッシングソリューション市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア、
    • 韓国
    • その他
  • 世界のその他の地域
    • 中東・アフリカ
    • 南米

第10章 競合情勢

  • 市場シェア分析
  • 競合ダッシュボード
  • 公開企業の株式:サマリー
  • 比較分析:主要企業の財務
  • 主な展開・成長戦略

第11章 企業プロファイル

  • MCKESSON CORPORATION
  • SPM MEDICARE PVT. LTD.
  • POLYMEDICURE
  • MEDEFIL, INC.
  • TIANHE PHARMACEUTICAL CO., LTD.
  • PENTAFERTE
  • BECTON, DICKINSON AND COMPANY
  • BAXTER
  • B. BRAUN SE
  • AMSINO INTERNATIONAL, INC
  • AQUABILITI
  • MEDLINE INDUSTRIES, LP

第12章 データの引用

図表

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL FLUSHING SOLUTION MARKET, BY TYPE, 2019-2035 (USD BILLION)
  • TABLE 3 GLOBAL FLUSHING SOLUTION MARKET, FOR SALINE-BASED SOLUTIONS, BY REGION, 2019-2035 (USD BILLION)
  • TABLE 4 GLOBAL FLUSHING SOLUTION MARKET, FOR HEPARIN-BASED SOLUTIONS, BY REGION, 2019-2035 (USD BILLION)
  • TABLE 5 GLOBAL FLUSHING SOLUTION MARKET, FOR OTHERS, BY REGION, 2019-2035 (USD BILLION)
  • TABLE 6 GLOBAL FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD BILLION)
  • TABLE 7 GLOBAL FLUSHING SOLUTION MARKET, FOR GASTROINTESTINAL PROCEDURES, BY REGION, 2019-2035 (USD BILLION)
  • TABLE 8 GLOBAL FLUSHING SOLUTION MARKET, FOR URINARY FLUSHING, BY REGION, 2019-2035 (USD BILLION)
  • TABLE 9 GLOBAL FLUSHING SOLUTION MARKET, FOR VASCULAR FLUSHING, BY REGION, 2019-2035 (USD BILLION)
  • TABLE 10 GLOBAL FLUSHING SOLUTION MARKET, FOR OTHERS, BY REGION, 2019-2035 (USD BILLION)
  • TABLE 11 GLOBAL FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD BILLION)
  • TABLE 12 GLOBAL FLUSHING SOLUTION MARKET, FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2019-2035 (USD BILLION)
  • TABLE 13 GLOBAL FLUSHING SOLUTION MARKET, FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2019-2035 (USD BILLION)
  • TABLE 14 GLOBAL FLUSHING SOLUTION MARKET, FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2019-2035 (USD BILLION)
  • TABLE 15 GLOBAL FLUSHING SOLUTION MARKET, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 16 NORTH AMERICA FLUSHING SOLUTIONS MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 17 NORTH AMERICA: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 18 NORTH AMERICA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 19 NORTH AMERICA: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 20 US: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 21 US: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 22 US: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 23 CANADA: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 24 CANADA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 25 CANADA: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 26 EUROPE: FLUSHING SOLUTIONS MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 27 EUROPE: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 28 EUROPE: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 29 EUROPE: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 30 GERMANY: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 31 GERMANY: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 32 GERMANY: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 33 FRANCE: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 34 FRANCE: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 35 FRANCE: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 36 UK: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 37 UK: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 38 UK: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 39 SPAIN: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 40 SPAIN: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 41 SPAIN: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 42 ITALY: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 43 ITALY: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 44 ITALY: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 45 REST OF EUROPE: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 46 REST OF EUROPE: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 47 REST OF EUROPE: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 48 ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 49 ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 50 ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 51 ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 52 CHINA: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 53 CHINA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 54 CHINA: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 55 INDIA: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 56 INDIA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 57 INDIA: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 58 JAPAN: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 59 JAPAN: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 60 JAPAN: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 61 AUSTRALIA: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 62 AUSTRALIA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 63 AUSTRALIA: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 64 SOUTH KOREA: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 65 SOUTH KOREA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 66 SOUTH KOREA: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 67 REST OF ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 68 REST OF ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 69 REST OF ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 70 REST OF THE WORLD: FLUSHING SOLUTION MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 71 REST OF THE WORLD: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 72 REST OF THE WORLD: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 73 REST OF THE WORLD: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 74 MIDDLE EAST AND AFRICA: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 75 MIDDLE EAST AND AFRICA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 76 MIDDLE EAST AND AFRICA: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 77 SOUTH AMERICA: FLUSHING SOLUTION MARKET, BY TYPE 2019-2035 (USD MILLION)
  • TABLE 78 SOUTH AMERICA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 79 SOUTH AMERICA: FLUSHING SOLUTION MARKET, BY END USER, 2019-2035 (USD MILLION)
  • TABLE 80 PARTNERSHIP
  • TABLE 81 MCKESSON CORPORATION: PRODUCTS OFFERED
  • TABLE 82 SPM MEDICARE PVT. LTD.: PRODUCTS OFFERED
  • TABLE 83 POLYMEDICURE: PRODUCTS OFFERED
  • TABLE 84 MEDEFIL, INC.: PRODUCTS OFFERED
  • TABLE 85 TIANHE PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 86 PENTAFERTE: PRODUCTS OFFERED
  • TABLE 87 PENTAFERTE: KEY DEVELOPMENTS
  • TABLE 88 BECTON, DICKINSON AND COMPANY: PRODUCT OFFERED
  • TABLE 89 BAXTER: PRODUCT OFFERED
  • TABLE 90 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 91 AMSINO INTERNATIONAL, INC: PRODUCTS OFFERED
  • TABLE 92 AQUABILITI: PRODUCTS OFFERED
  • TABLE 93 MEDLINE INDUSTRIES, LP: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL FLUSHING SOLUTION MARKET: STRUCTURE
  • FIGURE 2 GLOBAL FLUSHING SOLUTION MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2035)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2035)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2035)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL FLUSHING SOLUTION MARKET
  • FIGURE 6 GLOBAL FLUSHING SOLUTION MARKET TYPE SEGMENT, 2024 & 2035 (USD MILLION)
  • FIGURE 7 GLOBAL FLUSHING SOLUTION MARKET, BY TYPE, 2024 & 2035 (USD BILLION)
  • FIGURE 8 GLOBAL FLUSHING SOLUTION MARKET SHARE (%), BY TYPE, 2024
  • FIGURE 9 GLOBAL FLUSHING SOLUTION MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
  • FIGURE 10 GLOBAL FLUSHING SOLUTION MARKET, BY APPLICATION, 2024 & 2035 (USD BILLION)
  • FIGURE 11 GLOBAL FLUSHING SOLUTION MARKET SHARE (%), BY APPLICATION,
  • FIGURE 12 GLOBAL FLUSHING SOLUTION MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
  • FIGURE 13 GLOBAL FLUSHING SOLUTION MARKET, BY END USER, 2024 & 2035 (USD BILLION)
  • FIGURE 14 GLOBAL FLUSHING SOLUTION MARKET SHARE (%), BY END USER, 2024
  • FIGURE 15 GLOBAL FLUSHING SOLUTION MARKET, BY REGION, 2024 & 2035 (USD MILLION)
  • FIGURE 16 GLOBAL FLUSHING SOLUTION MARKET SHARE (%), BY REGION, 2024
  • FIGURE 17 NORTH AMERICA MARKET ANALYSIS: FLUSHING SOLUTION MARKET, 2019-2035 (USD MILLION)
  • FIGURE 18 NORTH AMERICA: FLUSHING SOLUTION MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION)
  • FIGURE 19 NORTH AMERICA: FLUSHING SOLUTION MARKET SHARE (%), BY COUNTRY, 2024
  • FIGURE 20 EUROPE MARKET ANALYSIS: FLUSHING SOLUTION MARKET, 2019-2035 (USD MILLION)
  • FIGURE 21 EUROPE: FLUSHING SOLUTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
  • FIGURE 22 EUROPE: FLUSHING SOLUTIONS MARKET SHARE, BY COUNTRY, 2024 (%)
  • FIGURE 23 ASIA-PACIFIC: FLUSHING SOLUTION MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
  • FIGURE 24 ASIA-PACIFIC: FLUSHING SOLUTION MARKET SHARE, BY COUNTRY, 2024 (%)
  • FIGURE 25 REST OF THE WORLD: FLUSHING SOLUTION MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION)
  • FIGURE 26 REST OF THE WORLD: FLUSHING SOLUTION MARKET SHARE, BY COUNTRY, 2024 (%)
  • FIGURE 27 GLOBAL FLUSHING SOLUTION MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024
  • FIGURE 28 COMPETITOR DASHBOARD: GLOBAL FLUSHING SOLUTION MARKET
  • FIGURE 29 MCKESSON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 30 MCKESSON CORPORATION: SWOT ANALYSIS
  • FIGURE 31 SPM MEDICARE PVT. LTD.: SWOT ANALYSIS
  • FIGURE 32 POLYMEDICURE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 33 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS
  • FIGURE 35 BAXTER: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 36 BAXTER: SWOT ANALYSIS
  • FIGURE 37 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 B. BRAUN SE: SWOT ANALYSIS
目次
Product Code: MRFR/HC/58153-CR

Global Flushing Solution Market Research Report by Type (Saline-Based Solutions, Heparin-Based Solutions, Others), by Application (Gastrointestinal Procedures, Urinary Flushing, Vascular Flushing, Others), by End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers, Research Laboratories & Institutes), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035

Industry Overview

The global flushing solution market will nearly double from USD 1,116.05 million in 2024 to USD 2,214.96 million in 2035 and expand at a CAGR of 6.59% by the forecast year. Flushing solutions are specially made sterile fluids that are used to keep medical devices working properly and safe during a procedure. They are an important part in opening devices that have been blocked, keeping them patent, and also reducing the chances of infection in catheters, IV lines, or any other devices for access. Patients can find doctors using saline and heparinized saline, as these are the most popular types of solutions.

Growing reliance on diagnostic procedures like colonoscopies and endoscopies is significantly fueling the Global Flushing Solution Market. Rising gastrointestinal disease cases, including cancers and chronic conditions, underscore the importance of accurate screenings. Flushing solutions ensure device patency, patient comfort, and effective preparation of the tract during these procedures. Supported by technological innovations and heightened awareness of preventive healthcare, demand for specialized solutions will accelerate globally over the next decade.

Key Company Development

Pentaferte Italia took a significant step forward in November 2023 by entering a distribution partnership with Medline Europe, expanding the reach of its sterile pre-filled syringe portfolio. Designed for vascular flushing procedures, these syringes come pre-filled with 0.9% saline solution (NaCl), ensuring reliability and reducing preparation time in clinical workflows. The partnership highlights Pentaferte's strategy of combining product innovation with strong distribution networks to meet growing demand across Europe. Known for its expertise in high-quality sterile solutions, Pentaferte reinforces its market leadership by offering healthcare professionals a dependable option for flushing both central and peripheral vascular devices. This collaboration with Medline Europe underscores the company's commitment to patient safety, efficiency, and strengthening its footprint in key European healthcare markets.

Key Players

Major players in the global flushing solution market are Becton, Dickson and Company, Baxter, B.Braun SE, Amsino International, Inc., Aquabiliti, Medline Industries, LP, McKesson Corporation, SPM Medicare Pvt. Ltd., Polymedicure, Medefil, Inc., Tianhe Pharmaceutical Co., Ltd, and Pentaferte.

Report Attribute Details

Market Size 2024 USD 1,116.05 Million

Market Size 2035 USD 2,214.96 Million

CAGR (2025-2035) 6.59%

Base Year 2024

Market Forecast Period 2025-2035

Historical Data 2019-2024

Market Segmentations

By Type: Saline-Based Solutions - 6.50%, Heparin-Based Solutions - 7.30%.

By Application: Gastrointestinal Procedures - 7.14%, Urinary Flushing - 6.45%.

By End User: Hospitals and Specialty Clinics - 6.17%, Ambulatory Surgical Centers - 8.02%.

Regional Analysis

The North American flushing solution market benefits from the technological innovations that are being adopted on a large scale and the patient-oriented care models. The United States dominates North America's flushing solution market with USD 385.92 million, while Canada follows with USD 51.90 million, reinforcing the U.S. as the key revenue contributor across the region. Demand for these products is notably high in the United States, and this is linked to the fact currently there are currently prevalent chronic diseases that require long-term intravenous therapy.

Europe is a major player in the world market for flushing solutions. Germany leads at USD 89.27 million, followed by the UK at USD 71.95 million and France at USD 64.06 million, showcasing the strength of Western European markets. The area is witnessing stable demand from the hospital sector, not only from public but also from private institutions, the most notable trend being in Western Europe.

The growth of the Asia Pacific market is driven by urbanization at a fast rate and healthcare infrastructure investments that have been on the rise. China tops the market with USD 73.70 million, while India follows at USD 56.36 million, underscoring their leadership in regional demand. Multinational companies are capitalizing on their presence by collaborating with local distributors.

In regions such as Latin America, the Middle East, and Africa, the flushing solution market is expanding at a moderate pace. Healthcare reforms led by the government in Latin America are beneficial as they increase patient access to modern care solutions. At the same time, the growing emphasis on advanced healthcare practices is making Gulf countries the new attractive markets.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES LIKE COLONOSCOPIES AND ENDOSCOPIES
    • 4.2.2 GROWING PREVALENCE OF KIDNEY STONES
  • 4.3 RESTRAINTS
    • 4.3.1 STRINGENT REGULATORY REQUIREMENTS
    • 4.3.2 LACK OF AWARENESS IN DEVELOPING REGIONS
  • 4.4 OPPORTUNITY
    • 4.4.1 RISING AGING POPULATION
    • 4.4.2 INCREASED ADOPTION OF MINIMALLY INVASIVE PROCEDURES

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF RIVALRY
  • 5.2 IMPACT OF COVID-19 ON THE GLOBAL FLUSHING SOLUTION MARKET

6 GLOBAL FLUSHING SOLUTION MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 SALINE-BASED SOLUTIONS
  • 6.3 HEPARIN-BASED SOLUTIONS
  • 6.4 OTHERS

7 GLOBAL FLUSHING SOLUTION MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 GASTROINTESTINAL PROCEDURES
  • 7.3 URINARY FLUSHING
  • 7.4 VASCULAR FLUSHING
  • 7.5 OTHERS

8 GLOBAL FLUSHING SOLUTION MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS AND SPECIALTY CLINICS
  • 8.3 AMBULATORY SURGICAL CENTERS (ASCS)
  • 8.4 RESEARCH LABORATORIES & INSTITUTES

9 GLOBAL FLUSHING SOLUTION MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 UK
    • 9.3.4 SPAIN
    • 9.3.5 ITALY
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 INDIA
    • 9.4.3 JAPAN
    • 9.4.4 AUSTRALIA,
    • 9.4.5 SOUTH KOREA
    • 9.4.6 REST OF ASIA-PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 MIDDLE EAST AND AFRICA
    • 9.5.2 SOUTH AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS, 2024
  • 10.3 COMPETITOR DASHBOARD
  • 10.4 PUBLIC PLAYERS STOCK SUMMARY
  • 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
  • 10.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.1.1 PARTNERSHIP

11 COMPANY PROFILES

  • 11.1 MCKESSON CORPORATION
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 SPM MEDICARE PVT. LTD.
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 POLYMEDICURE
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 KEY STRATEGIES
  • 11.4 MEDEFIL, INC.
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 TIANHE PHARMACEUTICAL CO., LTD.
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 KEY STRATEGIES
  • 11.6 PENTAFERTE
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY STRATEGIES
  • 11.7 BECTON, DICKINSON AND COMPANY
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGIES
  • 11.8 BAXTER
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 B. BRAUN SE
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 AMSINO INTERNATIONAL, INC
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES
  • 11.11 AQUABILITI
    • 11.11.1 COMPANY OVERVIEW
    • 11.11.2 FINANCIAL OVERVIEW
    • 11.11.3 PRODUCT OFFERED
    • 11.11.4 KEY DEVELOPMENTS
    • 11.11.5 KEY STRATEGIES
  • 11.12 MEDLINE INDUSTRIES, LP
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 FINANCIAL OVERVIEW
    • 11.12.3 PRODUCT OFFERED
    • 11.12.4 KEY DEVELOPMENTS
    • 11.12.5 KEY STRATEGIES

12 DATA CITATIONS